SCHEMBL18409176

SCHEMBL18409176

Cn1cnc2c(NC(=O)C3CC3)nc(Nc3ccc(C#N)cc3CC(F)F)cc21

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 4/20 0.48
▸ JAK2 O60674 2/20 0.48
▸ JAK1 P23458 2/20 0.48
▸ JAK3 P52333 2/20 0.48
▸ ABL1 P00519 1/20 0.37
▸ GNRHR P30968 1/20 0.37
▸ TBK1 Q9UHD2 3/20 0.34
▸ EGLN2 Q96KS0 3/20 0.34
▸ GPR119 Q8TDV5 2/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ PRKDC P78527 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ BRAF P15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398581 0.91 JAK2 (0.53) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18409117 0.87 TYK2 (0.55) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18409263 0.83 TYK2 (0.52) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18398424 0.81 GPR6 (0.39) —
SCHEMBL18409114 0.80 TYK2 (0.46) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18409285 0.80 TYK2 (0.62) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18409205 0.80 JAK2 (0.40) TYK2JAK2JAK1JAK3EGLN2
SCHEMBL18409202 0.79 TYK2 (0.53) TYK2JAK2JAK1JAK3ABL1
SCHEMBL18409528 0.78 TYK2 (0.65) TYK2JAK2JAK1JAK3GNRHR
SCHEMBL18409287 0.78 JAK2 (0.47) TYK2JAK2JAK1JAK3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback